NASDAQ:ADTX

Aditxt Q1 2025 Earnings Results & Report

Aditxt logo
$0.0002 0.00 (0.00%)
As of 03:57 PM Eastern

Aditxt beat analyst earnings expectations but missed on revenue in its Q1 2025 results, released May 15, 2025. The company reported EPS of -$198,192.96 versus the -$644,371,200.00 consensus estimate, while revenue of $1 thousand fell short of the $425 thousand estimate by $424 thousand.

Earnings Announcement Details

Quarter
Q1 2025
Report Date
Time
Before Market Opens

Aditxt EPS Results

Actual EPS
-$198,192.96
Consensus EPS
-$644,371,200.00
Beat/Miss
Beat by +$644,173,007.04
One Year Ago EPS
N/A

Aditxt Revenue Results

Actual Revenue
$1 thousand
Expected Revenue
$425 thousand
Beat/Miss
Missed by -$424.00 thousand
YoY Revenue Growth
N/A

Upcoming Earnings

Aditxt's next earnings date is estimated for Wednesday, December 2, 2026, based on past reporting schedules.

Conference Call Resources

Aditxt Q1 2025 Earnings FAQ

Aditxt (NASDAQ:ADTX) reported earnings of -$198,192.96 per share for Q1 2025, beating the consensus estimate of -$644,371,200.00. The report was announced on Thursday, May 15, 2025.

Aditxt reported revenue of $1 thousand for Q1 2025, against a consensus estimate of $425 thousand.

Aditxt's next earnings date is estimated for Wednesday, December 2, 2026. MarketBeat tracks confirmed and estimated earnings dates for Aditxt on the company's earnings history page.

Aditxt Earnings Headlines

Aditxt Faces Nasdaq Delisting, Moves Fully to OTC
Pentagon magnet restrictions take effect January 1, 2027
A NASDAQ-listed company has signed a term sheet outlining a potential 75-year agreement with the U.S. Army. It would build and operate a rare earth processing facility on an active military base, with the Army receiving first right to production. The timing matters. New Pentagon restrictions on certain Chinese-origin rare earth magnets take effect January 1, 2027, while China controls more than 90% of global rare earth processing. The company's mine-to-magnet platform spans feedstock agreements, processing facilities, metallization technology, and downstream manufacturing, with initial commercial output targeted for 2027.tc pixel
Aditxt Stock Dividends | NASDAQ:ADTX | Benzinga
See More Aditxt Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aditxt? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aditxt and other key companies, straight to your email.

About Aditxt

Aditxt (NASDAQ:ADTX) is a biotechnology company focused on developing technologies for immune-system monitoring and modulation. Its AditxtScore platform is designed to measure and profile immune responses, with potential applications in tracking immune health and supporting personalized care.

The company has also pursued immune-reprogramming approaches intended to promote immune tolerance in areas such as autoimmune disease, allergies and transplant rejection. Through its operating businesses and strategic initiatives, Aditxt has expanded its activities into diagnostics and other health-related technologies.

View Aditxt Profile